277 related articles for article (PubMed ID: 30060933)
1. Colorectal cancer prevention in patients with ulcerative colitis.
Lopez A; Pouillon L; Beaugerie L; Danese S; Peyrin-Biroulet L
Best Pract Res Clin Gastroenterol; 2018; 32-33():103-109. PubMed ID: 30060933
[TBL] [Abstract][Full Text] [Related]
2. Should we sound the alarm? Dysplasia and colitis-associated colorectal cancer.
Ren LL; Fang JY
Asian Pac J Cancer Prev; 2011; 12(8):1881-6. PubMed ID: 22292619
[TBL] [Abstract][Full Text] [Related]
3. Chemoprevention of colorectal cancer in ulcerative colitis: digging deep in current evidence.
Bezzio C; Festa S; Saibeni S; Papi C
Expert Rev Gastroenterol Hepatol; 2017 Apr; 11(4):339-347. PubMed ID: 28165825
[TBL] [Abstract][Full Text] [Related]
4. [Colorectal cancer in inflammatory bowel disease].
Henriksen M; Moum B
Tidsskr Nor Laegeforen; 2007 Oct; 127(20):2696-9. PubMed ID: 17952155
[TBL] [Abstract][Full Text] [Related]
5. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.
Rutter M; Saunders B; Wilkinson K; Rumbles S; Schofield G; Kamm M; Williams C; Price A; Talbot I; Forbes A
Gastroenterology; 2004 Feb; 126(2):451-9. PubMed ID: 14762782
[TBL] [Abstract][Full Text] [Related]
6. Studies in longstanding ulcerative colitis with special reference to malignant transformation of the colorectal mucosa.
Löfberg R
Acta Chir Scand Suppl; 1989; 552():1-45. PubMed ID: 2800882
[TBL] [Abstract][Full Text] [Related]
7. Chemoprevention of Colitis-Associated Dysplasia or Cancer in Inflammatory Bowel Disease.
Hsiao SW; Yen HH; Chen YY
Gut Liver; 2022 Nov; 16(6):840-848. PubMed ID: 35670121
[TBL] [Abstract][Full Text] [Related]
8. Ulcerative colitis-associated colorectal cancer.
Yashiro M
World J Gastroenterol; 2014 Nov; 20(44):16389-97. PubMed ID: 25469007
[TBL] [Abstract][Full Text] [Related]
9. Efficiency of Colorectal Cancer Surveillance in Patients with Ulcerative Colitis: 38 Years' Experience in a Patient Cohort from a Defined Population Area.
Rutegård M; Palmqvist R; Stenling R; Lindberg J; Rutegård J
Scand J Surg; 2017 Jun; 106(2):133-138. PubMed ID: 27431978
[TBL] [Abstract][Full Text] [Related]
10. Will a 5-ASA a day keep the cancer (and dysplasia) away?
Rubin DT; Lashner BA
Am J Gastroenterol; 2005 Jun; 100(6):1354-6. PubMed ID: 15929769
[TBL] [Abstract][Full Text] [Related]
11. Chronic inflammatory bowel disease and cancer.
Pohl C; Hombach A; Kruis W
Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
[TBL] [Abstract][Full Text] [Related]
12. Surveillance colonoscopy for colitis-associated dysplasia and cancer in ulcerative colitis patients.
Hata K; Kishikawa J; Anzai H; Shinagawa T; Kazama S; Ishii H; Nozawa H; Kawai K; Kiyomatsu T; Tanaka J; Tanaka T; Nishikawa T; Otani K; Yasuda K; Yamaguchi H; Ishihara S; Sunami E; Kitayama J; Watanabe T
Dig Endosc; 2016 Apr; 28(3):260-5. PubMed ID: 26096182
[TBL] [Abstract][Full Text] [Related]
13. The role of chemoprevention of colorectal cancer with 5-aminosalicylates in ulcerative colitis.
Herfarth H
Dig Dis; 2012; 30 Suppl 2():55-9. PubMed ID: 23207933
[TBL] [Abstract][Full Text] [Related]
14. Dysplastic lesions in ulcerative colitis: changing paradigms.
Allen PB; Kamm MA; De Cruz P; Desmond PV
Inflamm Bowel Dis; 2010 Nov; 16(11):1978-83. PubMed ID: 20803510
[TBL] [Abstract][Full Text] [Related]
15. [Colorectal cancer in ulcerative colitis].
Laugesen KB; Tøttrup A
Ugeskr Laeger; 2014 Jan; 176(4A):V07130441. PubMed ID: 25347248
[TBL] [Abstract][Full Text] [Related]
16. Chemoprevention of colorectal cancer in ulcerative colitis.
Croog VJ; Ullman TA; Itzkowitz SH
Int J Colorectal Dis; 2003 Sep; 18(5):392-400. PubMed ID: 12904996
[TBL] [Abstract][Full Text] [Related]
17. Critical review of the evidence on 5-aminosalicilate for chemoprevention of colorectal cancer in ulcerative colitis: a methodological question.
Margagnoni G; Pagnini C; Menasci F; Festa S; Delle Fave G
Curr Clin Pharmacol; 2014 Feb; 9(1):84-90. PubMed ID: 24218994
[TBL] [Abstract][Full Text] [Related]
18. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
Rubin DT; Rothe JA; Hetzel JT; Cohen RD; Hanauer SB
Gastrointest Endosc; 2007 Jun; 65(7):998-1004. PubMed ID: 17451704
[TBL] [Abstract][Full Text] [Related]
19. [Management of ulcerative colitis].
Rammert Ch; Kullak-Ublick GA
Ther Umsch; 2003 Mar; 60(3):145-50. PubMed ID: 12693317
[TBL] [Abstract][Full Text] [Related]
20. Cancer surveillance strategies in ulcerative colitis: the need for modernization.
Efthymiou M; Taylor AC; Kamm MA
Inflamm Bowel Dis; 2011 Aug; 17(8):1800-13. PubMed ID: 21089179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
